NCBI National Center for Biotechnology Information |
3L16: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer | |||||||||||||||
* Click molecule labels to explore molecular sequence information.
|